When was Parabilis Medicines's last funding round?

Parabilis Medicines's most recent recorded round was Later Stage VC (Series F) in Jan 2026, raising $305.0M.

PrivateMarketView

How much has Parabilis Medicines raised?

$812.0Macross 3 recorded rounds · Nov 2022 – Jan 2026

Most recently, Parabilis Medicines raised $305.0M in its Later Stage VC (Series F) (Jan 2026).

Free account

More of Parabilis Medicines with a free account

No card required

Membership and data by Private Market View

3 rounds

Jan 2026Later Stage VC (Series F)$305.0M▮

+ 2 more investors · free account

Jan 2025Later Stage VC (Series E)$145.0M▮

+ 2 more investors · free account

Nov 2022Later Stage VC (Series D)$178.0M▮

+ 1 more investors · free account

Parabilis Medicines has raised $812 million across 3 recorded rounds since 2022. The largest was a $305 million Series F in Jan 2026.

38 investors are on record for Parabilis Medicines, including General Catalyst, Fidelity Management & Research Company, RA Capital Management and GV. By type, the record holds 14 venture capital firms, 3 hedge funds and 2 private equity firms. The Series F in Jan 2026 drew 21 investors.

For fundraisers

Raising for a company like Parabilis Medicines?

38 investors have backed Parabilis Medicines — start your target list with the firms already writing checks in drug discovery.

How much has Parabilis Medicines raised?: Parabilis Medicines has raised $812.0M in total across 3 recorded funding rounds.
When was Parabilis Medicines's last funding round?: Parabilis Medicines's most recent recorded round was Later Stage VC (Series F) in Jan 2026, raising $305.0M.